Bosentan improves functional class, pulmonary artery systolic pressure, and DLCO in scleroderma patients with pulmonary hypertension: a possible synergy with iloprost

J Rheumatol. 2006 Sep;33(9):1915-6; author reply 1916.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology
  • Male
  • Middle Aged
  • Pulmonary Artery / physiopathology
  • Respiratory Function Tests
  • Retrospective Studies
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / physiopathology
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan